Fennec Pharmaceuticals Inc. (FENC) is the 19th largest of 40 Generic Drugs companies by market capitalisation, at 432.85 Mn, behind Amphastar Pharmaceuticals, Inc. at 1.01 Bn. The table below compares all 40 on 8 financial metrics.
| # | Ticker | Company | match | industry_code | industry_group | industry_group_code | Market Capitalization | P/E | P/S | Enterprise Value |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | TEVA | Teva Pharmaceutical Industries Ltd | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 42.41 Bn | 60.93 | 2.45 | 38.75 Bn |
| 2 | VTRS | Viatris Inc | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 19.68 Bn | -47.91 | 1.34 | 18.79 Bn |
| 3 | RDY | Dr Reddys Laboratories Ltd | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 9.95 Bn | 788.76 | 2.72 | 9.78 Bn |
| 4 | AMRX | Amneal Pharmaceuticals, Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 5.56 Bn | 25.83 | 1.78 | 5.43 Bn |
| 5 | BHC | Bausch Health Companies Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 2.45 Bn | -2.25 | 0.23 | 0.62 Bn |
| 6 | ALVO | Alvotech | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 1.55 Bn | -5.56 | 4.51 | 1.55 Bn |
| 7 | ANIP | Ani Pharmaceuticals Inc | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 1.51 Bn | 13.96 | 1.54 | 1.15 Bn |
| 8 | AMPH | Amphastar Pharmaceuticals, Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 1.01 Bn | 12.13 | 1.39 | 0.72 Bn |
| 9 | FENC | Fennec Pharmaceuticals Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.43 Bn | -97.58 | 8.05 | 0.39 Bn |
| 10 | RDHL | RedHill Biopharma Ltd. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.19 Bn | -428.85 | 36.65 | 0.19 Bn |
| 11 | NTRB | NutriBand Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.07 Bn | -2.39 | 39.65 | 0.07 Bn |
| 12 | BGM | BGM Group Ltd. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | — | — | 0.02 Bn |
| 13 | ETST | Earth Science Tech, Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | 6.76 | 0.73 | 0.02 Bn |
| 14 | NXPL | NextPlat Corp | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -2.53 | 0.52 | 0.01 Bn |
| 15 | COSM | Cosmos Health Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.80 | 0.22 | 0.01 Bn |
| 16 | SCNX | Scienture Holdings, Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.91 | 35.44 | 0.01 Bn |
| 17 | AEON | AEON Biopharma, Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.25 | — | 0.01 Bn |
| 18 | PMHS | Polomar Health Services, Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.88 | 2.67 | 0.01 Bn |
| 19 | SXTP | 60 Degrees Pharmaceuticals, Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.38 | 2.23 | 0.00 Bn |
| 20 | SBFM | Sunshine Biopharma Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.27 | 0.04 | -0.01 Bn |
| 21 | QNRX | Quoin Pharmaceuticals, Ltd. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | — | — | 0.00 Bn |
| 22 | PRFX | PRF Technologies Ltd. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.18 | 53.74 | -0.01 Bn |
| 23 | GRMLW | Greenland Mines Ltd | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.02 | — | -0.01 Bn |
| 24 | ABT | Abbott Laboratories | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 188.53 Bn | 34.75 | 4.05 | 182.93 Bn |
| 25 | PFE | Pfizer Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 162.07 Bn | 37.10 | 2.54 | 150.37 Bn |
| 26 | BIIB | Biogen Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 32.63 Bn | 39.10 | 3.25 | 31.34 Bn |
| 27 | BAX | Baxter International Inc | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 13.36 Bn | 580.95 | 1.20 | 11.21 Bn |
| 28 | CORT | Corcept Therapeutics Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 11.76 Bn | 217.04 | 14.16 | 11.46 Bn |
| 29 | BLCO | Bausch & Lomb Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 6.45 Bn | -39.57 | 1.21 | 6.07 Bn |
| 30 | HIMS | Hims & Hers Health, Inc. | secondary | H-16 | Healthcare Providers | HG-04 | 6.40 Bn | -45.09 | 2.48 | 5.56 Bn |
| 31 | LQDA | Liquidia Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 6.11 Bn | 44.08 | 13.55 | 5.83 Bn |
| 32 | OGN | Organon & Co. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.62 Bn | 17.31 | 0.59 | 2.49 Bn |
| 33 | HROW | Harrow, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.44 Bn | -43.13 | 5.24 | 1.36 Bn |
| 34 | DERM | Journey Medical Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.22 Bn | -59.33 | 3.18 | 0.19 Bn |
| 35 | SLGL | Sol-Gel Technologies Ltd. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.19 Bn | -18.50 | 108.08 | 0.15 Bn |
| 36 | NRXP | NRX Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.13 Bn | -6.22 | 38.18 | 0.10 Bn |
| 37 | AYTU | Aytu Biopharma, Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.76 | 0.41 | 0.00 Bn |
| 38 | HIND | Vyome Holdings, Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -1.31 | 120.60 | 0.01 Bn |
| 39 | MGRX | Mangoceuticals, Inc. | secondary | H-16 | Healthcare Providers | HG-04 | 0.01 Bn | -0.44 | 22.77 | 0.01 Bn |
| 40 | FCHS | First Choice Healthcare Solutions, Inc. | secondary | H-14 | Healthcare Providers | HG-04 | 0.00 Bn | -0.04 | — | 0.00 Bn |